Cre8™ unique technology in challenging daily practice

David Antoniucci; Roxana Mehran; Giuseppe De Luca; Holger Nef; Mathias Vrolix; Ahmed Khashaba; Katrina Mountfort

doi:10.15420/icr.2014.9.3.180

Cre8™ unique technology in challenging daily practice

David Antoniucci, Roxana Mehran, Giuseppe De Luca, Holger Nef, Mathias Vrolix, Ahmed Khashaba, Katrina Mountfort

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention (PCI) procedures. However, first-generation DES were associated with safety concerns arising from the persistence of durable polymers, including late stent thrombosis. The Cre8™ DES is a novel polymer-free stent designed to overcome these issues. In a presentation at EuroPCR 2014, two clinical cases were discussed. The first was a case of high bleeding risk; the second was the case of multivessel disease with a significant risk of stent restenosis. Together, these cases illustrated the complexity of decision-making in PCI in daily practice. In both cases, the Cre8™ DES offered a safe and effective solution to these challenging cases.

Original language	English
Pages (from-to)	180-183
Number of pages	4
Journal	Interventional Cardiology: Reviews, Research, Resources
Volume	9
Issue number	3
DOIs	https://doi.org/10.15420/icr.2014.9.3.180
State	Published - 2014
Externally published	Yes

Keywords

Percutaneous coronary intervention
Polymer-free drug eluting stent

Access to Document

10.15420/icr.2014.9.3.180

Cite this

@article{c363b17eabbf48239a276aa69ce34377,

title = "Cre8{\texttrademark} unique technology in challenging daily practice",

abstract = "The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention (PCI) procedures. However, first-generation DES were associated with safety concerns arising from the persistence of durable polymers, including late stent thrombosis. The Cre8{\texttrademark} DES is a novel polymer-free stent designed to overcome these issues. In a presentation at EuroPCR 2014, two clinical cases were discussed. The first was a case of high bleeding risk; the second was the case of multivessel disease with a significant risk of stent restenosis. Together, these cases illustrated the complexity of decision-making in PCI in daily practice. In both cases, the Cre8{\texttrademark} DES offered a safe and effective solution to these challenging cases.",

keywords = "Percutaneous coronary intervention, Polymer-free drug eluting stent",

author = "David Antoniucci and Roxana Mehran and {De Luca}, Giuseppe and Holger Nef and Mathias Vrolix and Ahmed Khashaba and Katrina Mountfort",

year = "2014",

doi = "10.15420/icr.2014.9.3.180",

language = "English",

volume = "9",

pages = "180--183",

journal = "Interventional Cardiology: Reviews, Research, Resources",

issn = "1756-1477",

publisher = "Radcliffe Cardiology",

number = "3",

}

TY - JOUR

T1 - Cre8™ unique technology in challenging daily practice

AU - Antoniucci, David

AU - Mehran, Roxana

AU - De Luca, Giuseppe

AU - Nef, Holger

AU - Vrolix, Mathias

AU - Khashaba, Ahmed

AU - Mountfort, Katrina

PY - 2014

Y1 - 2014

N2 - The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention (PCI) procedures. However, first-generation DES were associated with safety concerns arising from the persistence of durable polymers, including late stent thrombosis. The Cre8™ DES is a novel polymer-free stent designed to overcome these issues. In a presentation at EuroPCR 2014, two clinical cases were discussed. The first was a case of high bleeding risk; the second was the case of multivessel disease with a significant risk of stent restenosis. Together, these cases illustrated the complexity of decision-making in PCI in daily practice. In both cases, the Cre8™ DES offered a safe and effective solution to these challenging cases.

AB - The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention (PCI) procedures. However, first-generation DES were associated with safety concerns arising from the persistence of durable polymers, including late stent thrombosis. The Cre8™ DES is a novel polymer-free stent designed to overcome these issues. In a presentation at EuroPCR 2014, two clinical cases were discussed. The first was a case of high bleeding risk; the second was the case of multivessel disease with a significant risk of stent restenosis. Together, these cases illustrated the complexity of decision-making in PCI in daily practice. In both cases, the Cre8™ DES offered a safe and effective solution to these challenging cases.

KW - Percutaneous coronary intervention

KW - Polymer-free drug eluting stent

UR - http://www.scopus.com/inward/record.url?scp=84938223736&partnerID=8YFLogxK

U2 - 10.15420/icr.2014.9.3.180

DO - 10.15420/icr.2014.9.3.180

M3 - Article

AN - SCOPUS:84938223736

SN - 1756-1477

VL - 9

SP - 180

EP - 183

JO - Interventional Cardiology: Reviews, Research, Resources

JF - Interventional Cardiology: Reviews, Research, Resources

IS - 3

ER -

Cre8™ unique technology in challenging daily practice

Abstract

Keywords

Access to Document

Fingerprint

Cite this